Trials / Completed
CompletedNCT00156273
Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer
A Pilot Study to Determine the Feasibility of Quantifying Apoptosis and Bcl-2 Expression in Circulating Tumor Cells (CTCs) in Women Undergoing Treatment for Metastatic Breast Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 69 (actual)
- Sponsor
- University of Michigan Rogel Cancer Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
We are trying to develop better ways to detect when cancer therapies are working.
Conditions
Timeline
- Start date
- 2005-04-01
- Primary completion
- 2008-10-01
- Completion
- 2008-10-01
- First posted
- 2005-09-12
- Last updated
- 2017-07-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00156273. Inclusion in this directory is not an endorsement.